These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 22367687)

  • 1. Dissolution medium responsive simvastatin release from biodegradable apatite cements and the therapeutic effect in osteoporosis rats.
    Hamada H; Ohshima H; Otsuka M
    J Appl Biomater Funct Mater; 2012 Jun; 10(1):22-8. PubMed ID: 22367687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone cell activity responsive drug release from biodegradable apatite/collagen nano-composite cements--in vitro dissolution medium responsive vitamin K2 release.
    Otsuka M; Hirano R
    Colloids Surf B Biointerfaces; 2011 Jul; 85(2):338-42. PubMed ID: 21458964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium-level responsive controlled drug delivery from implant dosage forms to treat osteoporosis in an animal model.
    Otsuka M; Matsuda Y; Baig AA; Chhettry A; Higuchi WI
    Adv Drug Deliv Rev; 2000 Aug; 42(3):249-58. PubMed ID: 10963839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oestradiol release from self-setting apatitic bone cement responsive to plasma-calcium level in ovariectomized rats, and its physicochemical mechanism.
    Otsuka M; Yoneoka K; Matsuda Y; Fox JL; Higuchi WI; Sugiyama Y
    J Pharm Pharmacol; 1997 Dec; 49(12):1182-8. PubMed ID: 9466340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteogenic effects in a rat osteoporosis model and femur defect model by simvastatin microcrystals.
    Zhu J; Zhang C; Jia J; Wang H; Leng H; Xu Y; Wu C; Zhang Q; Song C
    Ann N Y Acad Sci; 2021 Mar; 1487(1):31-42. PubMed ID: 33098131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rat osteoporotic spine model for the evaluation of bioresorbable bone cements.
    Wang ML; Massie J; Perry A; Garfin SR; Kim CW
    Spine J; 2007; 7(4):466-74. PubMed ID: 17630145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of calcium phosphate nanocapsules including simvastatin/deoxycholic acid assembly, and their therapeutic effect in osteoporosis model mice.
    Ito T; Takemasa M; Makino K; Otsuka M
    J Pharm Pharmacol; 2013 Apr; 65(4):494-502. PubMed ID: 23488777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteogenic and anti-osteoporotic effects of risedronate-added calcium phosphate silicate cement.
    Gong T; Chen Y; Zhang Y; Zhang Y; Liu X; Troczynski T; Häfeli UO
    Biomed Mater; 2016 Jul; 11(4):045002. PubMed ID: 27388334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Simvastatin on bone healing around titanium implants in osteoporotic rats.
    Du Z; Chen J; Yan F; Xiao Y
    Clin Oral Implants Res; 2009 Feb; 20(2):145-50. PubMed ID: 19077150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single CT-guided percutaneous intraosseous injection of thermosensitive simvastatin/poloxamer 407 hydrogel enhances vertebral bone formation in ovariectomized minipigs.
    Tan J; Fu X; Sun CG; Liu C; Zhang XH; Cui YY; Guo Q; Ma T; Wang H; Du GH; Yin X; Liu ZJ; Leng HJ; Xu YS; Song CL
    Osteoporos Int; 2016 Feb; 27(2):757-67. PubMed ID: 26223190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness of the controlled release of simvastatin from β-TCP macrosphere in the treatment of OVX mice.
    Chou J; Ito T; Otsuka M; Ben-Nissan B; Milthorpe B
    J Tissue Eng Regen Med; 2016 Mar; 10(3):E195-203. PubMed ID: 23784984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of plasma-calcium-level-responsive oestradiol release from apatitic bone cement on bone mineral density in ovariectomized rats.
    Otsuka M; Yoneoka K; Matsuda Y; Fox JL; Higuchi WI
    J Pharm Pharmacol; 1999 Apr; 51(4):475-81. PubMed ID: 10385221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of injectable auto-forming alginate gel containing simvastatin with amorphous calcium phosphate as a controlled release medium and their therapeutic effect in osteoporosis model rat.
    Ito T; Saito M; Uchino T; Senna M; Iafisco M; Prat M; Rimondini L; Otsuka M
    J Mater Sci Mater Med; 2012 May; 23(5):1291-7. PubMed ID: 22391994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled release of simvastatin from biomimetic β-TCP drug delivery system.
    Chou J; Ito T; Bishop D; Otsuka M; Ben-Nissan B; Milthorpe B
    PLoS One; 2013; 8(1):e54676. PubMed ID: 23349949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of combined human parathyroid hormone (1-34) and simvastatin treatment on osseous integration of hydroxyapatite-coated titanium implants in the femur of ovariectomized rats.
    Tao ZS; Zhou WS; Tu KK; Huang ZL; Zhou Q; Sun T; Lv YX; Cui W; Yang L
    Injury; 2015 Nov; 46(11):2164-9. PubMed ID: 26404665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral delivery of zoledronic acid by non-covalent conjugation with lysine-deoxycholic acid: In vitro characterization and in vivo anti-osteoporotic efficacy in ovariectomized rats.
    Jeon OC; Seo DH; Kim HS; Byun Y; Park JW
    Eur J Pharm Sci; 2016 Jan; 82():1-10. PubMed ID: 26542347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the drug release pattern of fresh and set simvastatin-loaded brushite cement.
    Mestres G; Kugiejko K; Pastorino D; Unosson J; Öhman C; Karlsson Ott M; Ginebra MP; Persson C
    Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():88-96. PubMed ID: 26478290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a novel osteoporotic drug delivery system in vitro: alendronate-loaded calcium phosphate cement.
    Jindong Z; Hai T; Junchao G; Bo W; Li B; Qiang WB
    Orthopedics; 2010 Aug; 33(8):. PubMed ID: 20704104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation, characterization, release kinetics, and in vitro cytotoxicity of calcium silicate cement as a risedronate delivery system.
    Gong T; Wang Z; Zhang Y; Sun C; Yang Q; Troczynski T; Häfeli UO
    J Biomed Mater Res A; 2014 Jul; 102(7):2295-304. PubMed ID: 23946228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo bone augmentation in an osteoporotic environment using bisphosphonate-loaded calcium deficient apatite.
    Verron E; Gauthier O; Janvier P; Pilet P; Lesoeur J; Bujoli B; Guicheux J; Bouler JM
    Biomaterials; 2010 Oct; 31(30):7776-84. PubMed ID: 20643480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.